SQNM, Sequenom Crashes: How to Profit

SQNM, the vendor of medical-diagnostic tests said that flawed research would cause it to throw away years of work. The company "failed to provide adequate protocols and controls" of results for its prenatal Down syndrome blood test.

Today the company fired CEO, and the head of research and development. The chief financial officer, and another officer resigned. An incredible situation which makes the company likely to fail. Whether it fails or recovers, here are the straddles to profit from either situation:







You may receive technical analysis and alerts on SQNM, sent automatically to you by entering the symbols in the Technical Trend Analysis Tool, (powered by INO).

Please do your own due dilligence.